Financials
- Financial year
- 2025
- Total assets
- €1.1m
- Profit
- €127,107
- Solvency
- 19.0%
Total assets▲ 15.2%
Net result
20192025
apotheek de plaats
ActiveSummary
apotheek de plaats has been active since 1992 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €214,239 and a net result of €127,107. Equity remains stable across the filed financial years (±0% per year). Its solvency ranks better than 30% of 12,678 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€1.1mtotal assets 2025
- Staff
- 1.8 FTE
- Equity
- €214,239
- Profit
- €127,107
Turnover not published (abbreviated format)
Structure
- Parent
- AM-PHARMA · 99%
2025 accounts 30 days early5 deeds in the Belgian Official Gazette
Why 85raises riskSector: Retail trade (NACE 47)Equity €214,239 (19.0% of total assets)lowers riskSize: 1.8 FTE, total assets €1.1mFounded in 1992Show the evidence
Checked score
Score 2025
85
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 44% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Average
Solvency
44-3
equity 19.0% of total assets
Liquidity
25-5
short-term debt 53.5% · cash 2.0%
Profitability
83+76
return on assets 11.2%
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.3%
12-2024: 0.3%● unchanged vs 11-2024
01-2025: 0.3%● unchanged vs 12-2024
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 1.3%▲ +1.0 percentage point vs 02-2025
04-2025: 1.3%● unchanged vs 03-2025
05-2025: 1.3%● unchanged vs 04-2025
06-2025: 1.3%● unchanged vs 05-2025
07-2025: 1.3%● unchanged vs 06-2025
08-2025: 1.3%● unchanged vs 07-2025
09-2025: 1.3%● unchanged vs 08-2025
10-2025: 1.3%● unchanged vs 09-2025
11-2025: 1.3%● unchanged vs 10-2025
12-2025: 1.3%● unchanged vs 11-2025
01-2026: 1.4%▲ +0.1 percentage points vs 12-2025
02-2026: 1.4%● unchanged vs 01-2026
03-2026: 1.5%▲ +0.1 percentage points vs 02-2026highest value
04-2026: 0.3%▼ -1.2 percentage points vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.3%● unchanged vs 05-2026
07-2026: 0.3%● unchanged vs 06-2026
08-2026: 0.3%● unchanged vs 07-2026lowest value
09-2026: 0.3%● unchanged vs 08-2026lowest value
10-2026: 0.3%● unchanged vs 09-2026
Credit of up to €18,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.37, compared with 1.66 in 2024, below the usual 1.5; short-term debt: 53.5% and cash: 2% of total assets), and 81% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 35% on solvency, 23% on liquidity, 76% on profitability and 41% on growth.
The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 31-03-2026, 30 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
30 days early
2024
71 days early
2023
21 days early
2022
34 days early
2021
45 days early
2020
32 days early
2019
36 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 38 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 27 March (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
30-09-2026 year end27-10-2026 today30-04-2027 deadline
- Annual accounts filedfinancial year 2025 · abbreviated…
- Back to profitnet €127,107
- Annual accounts filedfinancial year 2024 · abbreviated…
Key points
By topic
Board & ownership
- Parent
- AM-PHARMA · 99%
Timeline
- Events
- 35
- Since
- 1994
- Next accounts
- by 30-04-2027
- 30-09-2024Weakest financial year
- 09-04-2024Annual accounts filed
- 27-03-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 08-07-1992
- Year ends
- 30-09
- Peppol
- Reachable for e-invoices
Key facts about apotheek de plaats
- What is the company number of apotheek de plaats?
- 0447.808.616. In Belgium the VAT number is the company number with BE in front: BE 0447.808.616.
- Where is apotheek de plaats based?
- The registered office is at Plaats 33, 8930 Menen.Company details
- What does apotheek de plaats do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of apotheek de plaats?
- Private limited company (BV).
- When was apotheek de plaats founded?
- On 08-07-1992.
- Is apotheek de plaats still active?
- Yes, apotheek de plaats is an active enterprise in the KBO register.
- How many employees does apotheek de plaats have?
- On average 1.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of apotheek de plaats?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
- Is apotheek de plaats profitable?
- In financial year 2025, apotheek de plaats made a profit of €127,107.
- Where can I find the annual accounts of apotheek de plaats?
- apotheek de plaats filed 33 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of apotheek de plaats due?
- By 30-04-2027, for financial year 2026.Timeline
Companies related to apotheek de plaats
Parent and group
- AM-PHARMA99%
Comparable companies
- BellipharmaSchaarbeek
- PHARMACIE VLEURGATBrussel
- PHARMACIE AMBIORIXBrussel
- APOTHEEK ALAERTSLeopoldsburg
- Centrumapotheek VosselaarVosselaar
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.